COVID-19 Hydroxychloroquine - Is it all over?
Clinical Impact of COVID-19 on Cancer Treatment
The Current State of Affairs in Antibiotic R&D published by ACS Infectious Diseases
The Academy of Medical Sciences' COVID-19 UK Rapid Response Project Goes Live
COVID-19 Panel Discussion: Successful Medical Affairs in the “New Normal” after COVID-19
Another string to Recarbrio’s bow in the fight against antibiotic-resistance
Clinical Impact of COVID-19 on Patients with Cancer
The new, “pandemic proof” world. Is it new or is COVID-19 just driving trends faster?
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention - Background and New FDA Guidance
COVID-19 Panel Discussion: Navigating translational/early clinical development during COVID-19